No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".
None.
No insider has filed a notice of proposed sale (Form 144) for Carisma Therapeutics Inc. in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
M
Merck & Co., Inc.
|
— | — | SOLD OUT | — | 0.0% | |
|
Shares held by quarter
|
||||||
|
UB
Union Bancaire Privee, UBP SA
|
785 | 0.00% | Unchanged | 2024 | 0.0% | |
|
Shares held by quarter
Peak holding785 (Q4'25)
Change over 8 quarters+785
Share of the company0.000%
|
||||||
1 more super investors behind a free account
See every manager holding Carisma Therapeutics Inc., how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
GA
Guggenheim Active Allocation Fund
Guggenheim Active Allocation Fund
|
$0.08 | 59 | 0.00% | 0.00% | August 31, 2026 |
Loading...